← Home / Virax Biolabs Group Ltd (VRAX)
Stock Analysis

Virax Biolabs Group Ltd (VRAX)

VRAX
VRAX · Healthcare • Biotechnology
3.15 -1.29%
Track VRAX in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when VRAX price is:
52W Range Position
3%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-24 17:54 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and structural levels before acting.
⚖️
✓
Fundamentals
Strong / Negative
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
3.00
↗
Break Above
No reliable confirmation level is currently available.
Not available
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
What's Driving VRAX?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 3.00 would weaken the current structure.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
49.9
Price Chart
VRAX — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-21
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$2.7M
Company size
EV
$-4.5M
Debt-adjusted value
P/S
221.3
Very high
P/B
0.3
Low book multiple
EV/EBIT
1.0
Low multiple
P/FCF
-0.8
Not meaningful
Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
6,331
↗ Strong
📈 Net Income
-6.06M
↘ Negative
🧮 EPS (Basic)
-1.62
↘ Negative
Virax Biolabs Group Ltd
Healthcare • Biotechnology
You Might Also Like